Javascript must be enabled to continue!
Rat hepatic glutaminase: identification of the full coding sequence and characterization of a functional promoter
View through CrossRef
Glutamine catabolism in mammalian liver is catalysed by a unique isoenzyme of phosphate-activated glutaminase. The full coding and 5′ untranslated sequence for rat hepatic glutaminase was isolated by screening λ ZAP cDNA libraries and a Charon 4a rat genomic library. The sequence produces a mRNA 2225 nt in length, encoding a polypeptide of 535 amino acid residues with a calculated molecular mass of 59.2 kDa. The deduced amino acid sequence of rat liver glutaminase shows 86% similarity to that of rat kidney glutaminase and 65% similarity to a putative glutaminase from Caenorhabditis elegans. A genomic clone to rat liver glutaminase was isolated that contains 3.5 kb of the gene and 7.5 kb of the 5′ flanking region. The 1 kb immediately upstream of the hepatic glutaminase gene (from -1022 to +48) showed functional promoter activity in HepG2 hepatoma cells. This promoter region did not respond to treatment with cAMP, but was highly responsive (10-fold stimulation) to the synthetic glucocorticoid dexamethasone. Subsequent 5′ deletion analysis indicated that the promoter region between -103 and +48 was sufficient for basal promoter activity. This region does not contain an identifiable TATA element, indicating that transcription of the glutaminase gene is driven by a TATA-less promoter. The region responsive to glucocorticoids was mapped to -252 to -103 relative to the transcription start site.
Portland Press Ltd.
Title: Rat hepatic glutaminase: identification of the full coding sequence and characterization of a functional promoter
Description:
Glutamine catabolism in mammalian liver is catalysed by a unique isoenzyme of phosphate-activated glutaminase.
The full coding and 5′ untranslated sequence for rat hepatic glutaminase was isolated by screening λ ZAP cDNA libraries and a Charon 4a rat genomic library.
The sequence produces a mRNA 2225 nt in length, encoding a polypeptide of 535 amino acid residues with a calculated molecular mass of 59.
2 kDa.
The deduced amino acid sequence of rat liver glutaminase shows 86% similarity to that of rat kidney glutaminase and 65% similarity to a putative glutaminase from Caenorhabditis elegans.
A genomic clone to rat liver glutaminase was isolated that contains 3.
5 kb of the gene and 7.
5 kb of the 5′ flanking region.
The 1 kb immediately upstream of the hepatic glutaminase gene (from -1022 to +48) showed functional promoter activity in HepG2 hepatoma cells.
This promoter region did not respond to treatment with cAMP, but was highly responsive (10-fold stimulation) to the synthetic glucocorticoid dexamethasone.
Subsequent 5′ deletion analysis indicated that the promoter region between -103 and +48 was sufficient for basal promoter activity.
This region does not contain an identifiable TATA element, indicating that transcription of the glutaminase gene is driven by a TATA-less promoter.
The region responsive to glucocorticoids was mapped to -252 to -103 relative to the transcription start site.
Related Results
Insights into Potent Therapeutical Antileukemic Agent L-glutaminase Enzyme Under Solid-state Fermentation: A Review
Insights into Potent Therapeutical Antileukemic Agent L-glutaminase Enzyme Under Solid-state Fermentation: A Review
Aim & objective:
To review the applications and production studies of reported antileukemic drug
L-glutaminase under Solid-state Fermentation (SSF).
Overview:
An amidohydrola...
Runahead threads
Runahead threads
Los temas de investigación sobre multithreading han ganado mucho interés en la arquitectura de computadores con la aparición de procesadores multihilo y multinucleo. Los procesador...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
Versatile and Valuable Utilization of Amidohydrolase L-glutaminase in Pharma and Food industries: A Review
Versatile and Valuable Utilization of Amidohydrolase L-glutaminase in Pharma and Food industries: A Review
L-glutaminase has versatile applications in pharma and food industries. In pharmaceutical industry,
L-glutaminase can be used as anti-oxidant and anti-cancer agent to treat Acute L...
Management of childhood esophageal varices: learnings from an advanced medical centre
Management of childhood esophageal varices: learnings from an advanced medical centre
Background: Variceal bleeding represents a significant clinical emergency with potential life-threatening implications in infants and children. Endoscopic band ligation is the stan...
Characterization of β-Actin Promoter from Nile Tilapia (Oreochromis niloticus)
Characterization of β-Actin Promoter from Nile Tilapia (Oreochromis niloticus)
<p>Promoter is one of the factors determining the successful of transgenesis. In this study we isolated and characterized β-actin promoter from Nile tilapia (tiBP) towards p...
Abstract 3561: HIF-1α stabilisation in triple receptor negative breast cancer is sensitive to glutaminase inhibition
Abstract 3561: HIF-1α stabilisation in triple receptor negative breast cancer is sensitive to glutaminase inhibition
Abstract
Increased expression of Hypoxia-Inducible Factor 1α (HIF-1α) in breast tumours is associated with poor survival outcome. HIF-1α promotes phenotypic adaptati...
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018
Abstract
Background
Several studies have demonstrated that systemic immune inflammation index (SII) has a positive relationship with hepatic steatosis. However, it is lack...

